![Amy Rabourn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Amy Rabourn formerly worked at Gemphire Therapeutics, Inc., as Finance Director from 2014 to 2019 and Opus Genetics, Inc., as Treasurer, Chief Financial & Accounting Officer in 2025.
Ms. Rabourn received her undergraduate degree and graduate degree from the University of Michigan.
Eerdere bekende functies van Amy Rabourn
| Bedrijven | Functie | Einde |
|---|---|---|
| OPUS GENETICS, INC. | Financieel Directeur/CFO | 02-09-2025 |
| METAVIA INC. | Financieel Directeur/CFO | 01-12-2019 |
Opleiding van Amy Rabourn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
